Nov 4, 2026: the T-Mobile dispute resets the outlook

Amdocs closed Nov 3 at $62.43, near the top of the range it had held since late September. It reported after the close and held its call at 5:00pm ET. The shares fell as low as $34.10 in after-hours trading and traded between $36.00 and $40.13 before the open, when InvestorsHub reported them down 39.4% at $37.83. The stock opened at $43.24, touched its low of $41.44 in the first five minutes and climbed to $46.39 at 10:45am. It drifted lower through the afternoon and closed at $43.66, down $18.77, on 9.3 million shares. The market value fell to about $4.7 billion.

What moved the stock:

  • A breach fight with T-Mobile. "Amdocs and T-Mobile have both issued notices to one another, asserting that the other party has materially breached" their agreements, the release said. Both sides threaten termination and monetary or other relief, including in arbitration.
  • A guide built for the worst case. On the call, Hortig said the outlook uses "conservative assumptions," including "a case of termination of our agreements with T-Mobile by either party." Management would not size T-Mobile revenue: "We cannot get into the details of the specific numbers right now."
  • Earnings fall faster than sales. Chief financial officer Tal Rozenfeld guided a non-GAAP operating margin of 19.2% to 19.8%, about 210 basis points lower than fiscal 2026, and cited "higher financing costs" from acquisitions.
  • Downgrades followed. Oppenheimer cut the stock to Market Perform from Outperform, MT Newswires reported, and InvestorsHub said at least three other analysts lowered their forecasts.

The selling was specific to Amdocs. T-Mobile rose 3.1% on the day, Accenture rose 3.9%, Cognizant rose 3.1% and EPAM slipped 0.6%, while the software fund IGV gained 0.9%. After the drop, RSI(14) stood at 18, the shares sat 27.6% below their 50-day average and 29.8% below their 200-day average, volume ran 9.3 times its 20-day average, and the stock was 49.0% below its 52-week high of $85.63. The rest of the session's movers are in today's biggest stock moves.

Bar chart of Amdocs quarterly revenue in millions of dollars: Q4 fiscal 2025 actual $1,150, Q4 fiscal 2026 actual $1,194, Q1 fiscal 2027 consensus $1,200 and Q1 fiscal 2027 guide midpoint $975

The numbers

MeasureQ4 FY2026Q4 FY2025Change
Revenue$1,194 million$1,150 million+3.8%
Non-GAAP EPS$1.98$1.83+8%
GAAP EPS$1.35$0.88+53%
Non-GAAP operating margin21.6%21.6%flat
Free cash flow$122 million$199 million-39%

For the full fiscal year, revenue rose 3.6% to $4.697 billion and non-GAAP EPS rose 6.0% to $7.41. The 12-month backlog ended at $3.50 billion, down about 9.6% on a pro forma basis, which management tied mainly to its T-Mobile assumptions. The pro forma figures remove about $360 million of fiscal 2026 revenue from hardware resale and a media business Amdocs is selling.

The fiscal 2027 guide calls for free cash flow of $440 million to $500 million. Applied to $7.41, the EPS guide implies roughly $5.19 to $5.48 a share. For the first quarter, Amdocs guided non-GAAP EPS of $1.27 to $1.33, against a consensus of $1.93, StockStory reported. Our guide to guidance changes explains why a cut like this usually matters more than the quarter just reported.

The bull case

The core business is not shrinking. Rozenfeld said "the rest of Amdocs' business is expected to grow mid-single digits in fiscal 2027," and management said the backlog outside T-Mobile grew at a mid-single-digit rate on a pro forma basis. Amdocs also signed an eight-year agreement with AT&T, its largest customer, which Hortig called "a landmark, first-of-its-kind deal," plus agreements for its aOS agentic software with VodafoneThree, VEON and Globe. Our earlier page on AT&T's October drop covers the customer's own pressures.

Because the guide assumes the worst for T-Mobile, any settlement would add to it. Management also set fiscal 2028 expectations of mid-single-digit revenue growth and high-single-digit earnings growth, and the board proposed a 3% dividend increase to $0.586 a quarter. At $43.66 the current $0.569 dividend yields about 5.2%. Our guide to valuing a litigation outcome shows how to weigh a binary dispute like this one.

The risks

The arbitration has no timetable and no disclosed size. Hortig said Amdocs is "prepared to fiercely defend our positions, including in arbitration," and Tal Liani of Bank of America asked on the call whether other large customers could follow; Hortig called the T-Mobile case isolated. Until it is resolved, the stock carries a risk that the guide may not fully capture, such as damages claims.

The balance sheet is also busier. Amdocs ended September with about $947 million of debt, took out $500 million of term loans in October and paid about $340 million in cash for EIS, an insurance software company. Rozenfeld said "we expect a slower pace of buyback activity in fiscal 2027," after $511 million of repurchases in fiscal 2026, which removes a source of demand for the shares. Our page on buybacks as catalysts covers why that matters. Margins should start the year well below the annual range and improve each quarter, so the next report will show the low point. Our explainer on earnings estimate revisions covers how a string of analyst cuts can keep weighing on a stock after the first drop.

What comes next

The first-quarter fiscal 2027 report is expected in early February 2027, around February 2. Before then, watch for any update on the T-Mobile arbitration or a settlement, further analyst cuts, the shareholder vote on the dividend increase at the January 2027 annual meeting, and whether the stock can close above the $46.39 high of Nov 4. A close above that level, or a settlement with T-Mobile, would undercut the Bearish case.